Miravant Medical Technologies Stock Total Debt
Miravant Medical Technologies fundamentals help investors to digest information that contributes to Miravant Medical's financial success or failures. It also enables traders to predict the movement of Miravant Stock. The fundamental analysis module provides a way to measure Miravant Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Miravant Medical stock.
Miravant |
Miravant Medical Technologies Company Total Debt Analysis
Miravant Medical's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Miravant Medical Total Debt | 10.32 M |
Most of Miravant Medical's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Miravant Medical Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Miravant Medical Technologies has a Total Debt of 10.32 M. This is 99.62% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The total debt for all United States stocks is 99.81% higher than that of the company.
Miravant Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Miravant Medical's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Miravant Medical could also be used in its relative valuation, which is a method of valuing Miravant Medical by comparing valuation metrics of similar companies.Miravant Medical is currently under evaluation in total debt category among its peers.
Miravant Fundamentals
Return On Asset | -1.1 | ||||
Current Valuation | 94.64 K | ||||
Price To Sales | 66.77 X | ||||
EBITDA | (13.33 M) | ||||
Net Income | (15.9 M) | ||||
Cash And Equivalents | 3.86 M | ||||
Cash Per Share | 0.10 X | ||||
Total Debt | 10.32 M | ||||
Current Ratio | 0.72 X | ||||
Book Value Per Share | (0.37) X | ||||
Cash Flow From Operations | (11.53 M) | ||||
Earnings Per Share | (0.41) X | ||||
Number Of Employees | 47 | ||||
Beta | -3.82 | ||||
Market Capitalization | 94.64 K | ||||
Total Asset | 7.51 M | ||||
Z Score | -3.3 | ||||
Annual Yield | 0.06 % | ||||
Net Asset | 7.51 M |
About Miravant Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Miravant Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Miravant Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Miravant Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Miravant Stock
If you are still planning to invest in Miravant Medical Tec check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Miravant Medical's history and understand the potential risks before investing.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |